Menu

Vibrio Infections On the Rise

Increases in oceanic populations of these bacteria—both pathogenic and not—is an effect of climate change, scientists show.

Aug 9, 2016
Alison F. Takemura

Vibrio choleraeWIKIMEDIA; TOM KIRN, RON TAYLOR, LOUISA HOWARDVibrio cholerae, V. vulnificus, and V. parahemolyticus can cause life-threatening infections. The risk they pose is also growing. As ocean temperatures have climbed over the last five decades, both Vibrio population sizes and infection rates have risen in regions the North Atlantic and the North Sea, according to a study published yesterday (August 8) in PNAS.

Scientists continue to observe an increase in outbreaks of marine infections—which can cause disease in humans, coral, and other organisms—as a result of changing ocean conditions. Researchers from the University of Genoa, Italy, and their international colleagues analyzed formalin-preserved plankton samples to determine changes in Vibrio abundances along the North Atlantic from 1958 to 2011.  

Study coauthor Rita Colwell of the Johns Hopkins Bloomberg School of Public Health in Baltimore, Maryland, expressed concern, particularly for places that haven’t historically experienced high rates of Vibrio infections, such as the rapidly warming Baltic Sea in Northern Europe. “They are now reporting more Vibrio in their waters,” she told New Scientist. “Not because it wasn’t there before, but because the water was too cold [for them to bloom]. Vibrio responds very quickly to temperature.”

The same pattern is also happening in the U.S. “We have seen Vibrio outbreaks in places that were previously too cold for Vibrio, like parts of Alaska,” Karen Wong from the US Centers for Disease Control and Prevention’s  division of foodborne, waterborne and environmental diseases, who was not involved in the study, told New Scientist.

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia

Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia

Horizon Discovery Group plc, a global leader in gene editing and gene modulation technologies, today announced the launch of its Myeloid DNA Reference Standard. The first-to-market large cell-line derived myeloid cancer reference standard designed enables faster, more reliable and more cost-effective assay validation, to support the market in bringing routine testing into practice.

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!